21 August 2025

ECO Animal Health Group plc

("ECO" or the "Company")

Result of General Meeting

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that at a General Meeting held earlier today, the single special resolution proposed was duly passed.

As a result, trustees of the ECO Animal Health Group Employee Benefit Trust will shortly commence limited on-market purchases of the Company's ordinary shares of 5 pence each.

Voting results from the General Meeting will be made available on the Company's website at https://ecoanimalhealth.com/investors/.

-Ends-

Contacts

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin^® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

Click here for more information: https://ecoanimalhealth.com